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▪ Pediatric patient intravenous (IV) insertion with pain 
control to reduce stress and anxiety for the patient 
during hospitalization 
 
▪ Needs to be a systematic approach by all healthcare 
workers when pediatric patient enters hospital and 
requires IV insertion 
 
▪ May enhance patient and family satisfaction of care 
with reduction of pain 
 






▪ In pediatric patients under the age of 14, does a doctor’s 
order for the use of EMLA cream for IV insertions compared 
to no order increase nursing compliance in the use of EMLA 
cream prior to IV insertion? 
▪ P – Pediatric patients requiring IV access 
▪ I – Part of the physician order; evidence that EMLA works 
▪ C – No physician order 
▪ O - Compliance of RNs applying EMLA prior to IV insertion (by 
education and experience) 
TRIGGER? 
▪ Knowledge v. Problem 
• Problem trigger: Utilization of EMLA cream 
for IV insertions. 
 
• Knowledge trigger: Education and knowledge 
of staff on effectiveness of EMLA cream and 
requirement of physician order for application 
of EMLA cream 
EVIDENCE 
▪ Search Engines Utilized: CINHAL, Medline, 
Google Scholar 
 
▪ Key Words: EMLA cream, pediatrics, IV 
insertion, venipuncture, pain 
















Study Name,  Journal, Year) 
METHODS SETTING/ POPULATION INTERVENTION OUTCOME MEASURES FINDINGS 
  
  
Baxter, A., Ewing, 
P., Young, G., Ware, 
A., Evans, N., and 
Manworren, R.  
“EMLA Application 













of children up to age 
18. Triage nurses 
estimated children 
who had a 50% 
likelihood of needing 
a venipuncture 
based on their 
clinical judgment 
and those charts 
were flagged with an 
orange data sheet.  
  
  
Urban free standing 
children’s hospital 
with an ED volume of 
greater than 100,000 
pediatric visits per 
year.  
  
The control group had no intervention 
placed as opposed to a placebo 
cream.  Days of the week were chosen 
by ED volume. Nurses then chose two 
sites they felt would be successful for 
IV insertion and applied EMLA and 
occlusive dressing in triage.   
  
After the IV had been placed, 
children’s pain score was 
documented as well as a 
survey by the caretaker on 
how satisfied they were with 
the staff’s concern for their 
child’s pain.  
Venipuncture success was 
identified as achieving the 
blood draw or IV with one 
needle and in one attempt. 
  
Of the recorded 154 venipuncture attempts, 72% 
were achieved successfully in one attempt. By 
analysis in this article, success in the EMLA group 
was 78% compared to 67% in those without EMLA. 






Access Pain in 
Children” Official 
Journal of the 
American Academy 




An overview of 
various trials 
utilizing EMLA cream 
as well as other 
methods for pain 
reduction. (A meta-
analysis and a 
randomized trial)  
  
This article explains 













1. The use of EMLA cream versus 
the use of a placebo cream 
2. The amount of EMLA cream 
utilized, 2.0 ml versus 0.5 ml 
  
Pain relief in the children 
receiving the EMLA cream 
  
1. This study showed that 85% of patients 
receiving EMLA exhibited a significant  
analgesic benefit 
2. This study found that the thicker layer of 
EMLA proved to be more effective in the 
reduction of pain.  
Papa, A., and 
Zempsky, W. “Nurse 
Perceptions of the 
Impact of Pediatric 
Peripheral Venous 






An electronic survey 
of 19 questions  was 





The Infusion Nurses 
Society, and the 
Society of Pediatric 
Nurses. The 
members received 
an email invitation 
to participate, and 
the survey was open 




members of the three 
societies listed. A 




No intervention included 
  
A 5 point Likert scale was 
used, ranging from 1 
(complete disagreement) to 5 
(complete agreement). ANOVA 
analysis used on results.  
  
Nurses stated that nonpharmalogical techniques are 
not as effective for pain management. They said 
pharmalogical techniques are much more effective 
but are utilized less often because they are 
associated with a slow onset of action, 
vasoconstriction, the need for physician 
authorization, and treatment delays. 92% of nurses 
stated that fast acting topical anesthetics  would 






▪ EMLA cream is a topical local anesthetic comprised of Lidocaine and 
Prilocaine which provides analgesic properties to the dermal and 
epidermal layers of the skin (Zempsky, 2014).  
 
▪ EMLA cream is proven to have analgesic properties and limited the pain 
felt in the pediatric population when utilized for a minimum of 1 hour 
prior to IV insertion (Baxter, et al. 2013). 
 
▪ In this study, 72% of venipuncture’s were achieved in one attempt with the 
use of EMLA cream prior to insertion (Baxter, et al. 2013). 
 
▪ A significant analgesic benefit was seen in the pediatric population when 
EMLA cream was applied as opposed to not used at all (Zempsky, 2014).  
 
▪ In the study by Papa, A. and Zempsky, W. (2014), nurses stated that 
pharmalogical techniques for reduction of pain are more effective than 
nonpharmalogical methods. However, they also stated they are used less 





Current Practice at LVHN 
▪ LVHN has a current policy for the application of 
EMLA cream in the Pediatric/Neonatal Patient 
Care Manual. 
 
▪ The policy states the maximum dose of EMLA 
cream based on the child’s weight, as well as the 
absorption time of one hour. 
 
▪ The policy states that a written order must be 
obtained from a physician prior to the application 
of the cream. 
 
IMPLEMENTATION 
1. Process Indicators and Outcomes  
• Indicators – HCAPS scores, patient reaction of invasive 
procedure 
• Outcome – Patient pain reduction, minimal attempts for IV 
insertion 
2. Baseline Data 
•  Pre-survey to nursing staff on 4B and 4C on EMLA cream usage, 
benefits/deterrents   
3. Design (EBP) Guideline(s)/Process 
• PHASE 1: Background research on effectiveness of EMLA cream and its 
utilization. Creation of survey for pediatric nurses on 4B and 4C 
• PHASE 2: Collection of data from completed surveys. Editing current 
EMLA cream policy in the Pediatric Patient Care Manual. Gaining support 
from staff for use of EMLA cream. 
• PHASE 3: Development of TLC education for health care staff. Meeting 
with the Pediatric Performance Committee and discussing project. 
Altering order set for IV insertions to allow use of EMLA as standing order.  
 
4. Implemented EBP on Pilot Units 
• EMLA cream as a physician’s standing order has not yet been 
implemented 
• Pilot Units would include Pediatric Units 4B and 4C; 
potentially Pediatric ICU and Children’s Emergency 
Department 
5. Evaluation (Post data) of Process & Outcomes 
• Post survey to nursing staff on 4B and 4C on EMLA cream 
usage; HCAPS score for pain management 
6. Modifications to the Practice Guideline 
• Update current EMLA cream policy and procedure @ LVHN to 
include EMLA cream as physician standing order prior to 
intravenous insertion 
7. Network Implementation 
• Practice change for physicians and nursing staff; standing 
order and increased usage 
Practice Change 
▪ Incorporating a standing physician order 
for EMLA cream whenever any IV insertion 
order is placed. 
 
▪ Education to all nursing staff regarding 
the correct timing and application of the 




▪ There is a lack of education in the nursing population 
regarding the effectiveness that EMLA cream has on 
the reduction of pain from invasive procedure. 
 
▪ Some side effects exist that may inhibit the 
effectiveness of EMLA cream in reduction of pain. For 
example, one side effect is vasoconstriction, which 
may lead to multiple attempts for IV insertion. 
 
▪ Based on a survey distributed to the nursing staff on 
the pediatric floor at LVHN, nurses would be more 
likely to utilize EMLA cream if a standing order from the 
physician was present. 
 
Next Steps 
▪ Creating education for nursing staff and 
physicians on benefits of standing order 
for EMLA cream 
 
▪ Monitoring compliance of the usage of 
EMLA cream prior to intravenous insertion 
Implications for LVHN 
▪ Increased patient and family satisfaction 
during intravenous insertion 
▪ Decreased pain during procedure for 
venipuncture 
▪ Decreased puncture attempts 




Strategic Dissemination of Results 
■ Use of TLC for healthcare staff 
education 
 
■ Discussion of use of EMLA cream during 
staff meetings 
 
■ Educational bulletin on Pediatric Unit 
Lessons Learned 
▪ Nursing staff requires additional education on the 
benefits of EMLA cream usage 
 
▪ Physician standing order of EMLA cream may increase 
usage 
 
▪ Time requirements for EMLA application is major 
deterrent for its use; however, benefits outweigh 
time factor 
 
▪ Patient and family expectation for pain management 
need to be top priority  
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